SRR

SRR (serine racemase) is the principal enzyme generating D-serine in the mammalian forebrain, where D-serine acts as an endogenous co-agonist of the NMDA receptor; genetic ablation of Srr in mice selectively depletes D-serine in frontal cortex, hippocampus, and striatum while sparing the cerebellum, which retains alternative biosynthetic routes (PMID:21906644). Biochemically the enzyme is bifunctional: in cells expressing SRR it both produces D-serine in racemase mode and converts D-serine to pyruvate in an alpha,beta-eliminase mode, with extracellular D-serine homeostasis further shaped by ASCT2-mediated transport (PMID:20091774). SRR activity also influences forebrain D-aspartic acid levels through a mechanism downstream of D-serine rather than altered D-aspartate catabolism (PMID:23439386). Pharmacological inhibition of SRR with the competitive inhibitor L-aspartic acid β-hydroxamate is neuroprotective in the diabetic retina and improves glucose tolerance, implicating the enzyme in retinal disease and metabolic homeostasis. The gene is expressed as multiple mRNA isoforms arising from alternative 5' exon usage (PMID:15953485). The yeast ortholog ILV1 encodes a functional threonine dehydratase whose conserved catalytic activity has been demonstrated by cross-kingdom complementation (PMID:3302681), and whose basal transcription is governed by REB1- and Dat1p-binding promoter elements acting synergistically in a distance-dependent manner (PMID:1448083, PMID:9613577).

1. 1987 High

   Established that the ancestral/ortholog gene product is a catalytically active enzyme, anchoring the protein's biochemical identity before its mammalian racemase role was known.

   Evidence Agrobacterium-mediated transfer of yeast ILV1 complementing a threonine dehydratase-deficient plant mutant with direct enzyme activity measurement

   PMID:3302681

   Open questions at the time

   • Does not address racemase activity or D-serine production
   • Yeast/plant system, not mammalian SRR
2. 1992 Medium

   Defined how basal transcription of the yeast ortholog is controlled, identifying a REB1-binding promoter element required for GCN4-independent expression.

   Evidence ILV1 promoter deletion/point-mutation analysis plus EMSA showing specific REB1 binding, with ABF1 site substitution

   PMID:1448083

   Open questions at the time

   • Yeast-specific transcriptional regulation; mammalian SRR promoter not addressed
   • Mechanism of REB1/ABF1 functional equivalence unresolved
3. 1997 Medium

   Mapped genetic suppressors that bypass loss of the yeast deaminase, illuminating metabolic compensation through CHA1 activation.

   Evidence Suppressor screen, epistasis, CHA1-lacZ reporter and metabolite pool measurement in yeast ilv1 mutants

   PMID:9323359

   Open questions at the time

   • Pertains to yeast amino acid metabolism, not mammalian D-serine function
4. 1998 Medium

   Showed that a second promoter element bound by Dat1p cooperates with the REB1 site to drive basal expression, defining a synergistic distance-dependent regulatory architecture for the ortholog.

   Evidence EMSA binding, promoter deletion, DAT1 deletion epistasis and reporter assays in yeast

   PMID:9613577

   Open questions at the time

   • Yeast-specific; relevance to mammalian SRR regulation unknown
5. 2001 Medium

   Determined that the ordered chromatin structure at the ortholog promoter is sequence-dictated and independent of the regulatory elements driving transcription.

   Evidence Nucleosome mapping with promoter deletion/substitution and in vivo transcription assays in yeast

   PMID:11706001

   Open questions at the time

   • Yeast-specific chromatin context
   • Does not connect to mammalian enzyme function
6. 2005 Medium

   Characterized the human gene structure, revealing four mRNA isoforms from alternative 5' exon usage in human brain.

   Evidence cDNA cloning, genomic structure determination and mutation screening

   PMID:15953485

   Open questions at the time

   • Functional differences among isoforms not defined
   • No protein-level or activity comparison of isoforms
7. 2010 Medium

   Demonstrated SRR is bifunctional, operating in both racemase and alpha,beta-eliminase modes, and linked extracellular D-serine to ASCT2 transport.

   Evidence SRR overexpression and RNAi in C6 glioma cells with D-serine/pyruvate measurement, [3H]D-serine uptake and immunoblot

   PMID:20091774

   Open questions at the time

   • Single cell line and single lab
   • Physiological balance between the two enzymatic modes in vivo unresolved
8. 2011 High

   Established SRR as the major source of forebrain D-serine through region-specific depletion in knockout mice.

   Evidence Srr-KO mice with HPLC amino acid quantification across brain regions and in vivo microdialysis

   PMID:21906644

   Open questions at the time

   • Identity of the cerebellar D-serine biosynthetic pathway not determined
   • Downstream NMDA receptor consequences not directly measured here
9. 2013 Medium

   Extended SRR's influence to forebrain D-aspartic acid levels, placing it upstream of D-aspartate via a D-serine-dependent route rather than altered catabolism.

   Evidence Srr-KO mice, HPLC quantification and DDO enzymatic activity assay

   PMID:23439386

   Open questions at the time

   • The SRR→D-serine→D-aspartate pathway is not biochemically resolved
   • Single lab
10. 2024 Medium

    Linked SRR activity to retinal neuroprotection and systemic glucose homeostasis using pharmacological inhibition in diabetic models.

    Evidence Competitive inhibitor L-ABH (oral and intravitreal) in db/db and diet-induced obesity mice with electroretinography, histological cell counts and glucose tolerance tests (preprint)

    Open questions at the time

    • Preprint, not peer-reviewed
    • Molecular mechanism linking SRR inhibition to glucose homeostasis not defined
    • Off-target effects of L-ABH not excluded

• How SRR's racemase versus eliminase activities are partitioned in vivo, what regulates the enzyme in mammalian neurons, and the mechanistic basis of its metabolic effects remain open.
• No structural or allosteric regulation data in the corpus
• Cerebellar D-serine source unidentified
• Mechanism connecting SRR to glucose homeostasis unknown